EUVIMEDEUVIMED entdecken
Open Access

CircCLMP Suppresses Anti-Tumor Immunity by Inhibiting Activation of IRF3 and Interferon Response in Microsatellite Instability-high Endometrial Cancer

Weijia Wen, Li Yuan, Peng Guo, Xueyuan Zhao, Linna Chen, Songlin Liu, Haolin Fan, Lin Lin, Yu Pan, Shiyi Chen, Yifang Xiao, Pan Liu und 5 weitere

International Journal of Biological Sciences · 2026

DOI: 10.7150/ijbs.125547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2026. Verfasst von Weijia Wen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P.R. China. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Interferon Regulatory Factor-3, Microsatellite Instability, RNA, Circular. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T cell infiltration in the tumor environment, and eventually mediating immune evasion and promoting the progression of MSI tumors. Targeted knockdown of circCLMP combined with anti-PD-1 inhibitor treatment effectively enhanced the anti-tumor effects in the preclinical MSI EC PDX model. For the first time, our study reported an immunoregulating circRNA in MSI EC, which may provide insights into developing new biomarkers and therapeutic targets for overcoming immunotherapy resistance in MSI EC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsInterferon Regulatory Factor-3Microsatellite InstabilityRNA, CircularInterferonsFemaleHumansAnimalsCell Line, TumorMiceProtein Serine-Threonine KinasesCD8-Positive T-Lymphocytes

Stichwörter der Autor:innen

IRF3anti-tumor immunitycircCLMPinterferon responsemicrosatellite instability-high endometrial cancer (MSI EC)

Substanzen

Interferon Regulatory Factor-3RNA, CircularIRF3 protein, humanInterferonsProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P.R. China.
  • Guangdong Provincial Clinical Research Center for Obstetrical and Gynecological Diseases, Guangzhou, Guangdong, P.R. China.
  • Department of Gynecology, Jinghong First People's Hospital, Xishuangbanna, Yunnan, P.R. China.

Zitieren

APA

Wen, W., Yuan, L., Guo, P., Zhao, X., Chen, L., Liu, S., Fan, H., Lin, L., Pan, Y., Chen, S., Xiao, Y., Liu, P., Wang, D., Jiang, H., Wang, W., Zhang, C., & Yao, S. (2026). CircCLMP Suppresses Anti-Tumor Immunity by Inhibiting Activation of IRF3 and Interferon Response in Microsatellite Instability-high Endometrial Cancer. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.125547

Vancouver

Wen W, Yuan L, Guo P, Zhao X, Chen L, Liu S, et al. CircCLMP Suppresses Anti-Tumor Immunity by Inhibiting Activation of IRF3 and Interferon Response in Microsatellite Instability-high Endometrial Cancer. International Journal of Biological Sciences. 2026. doi:10.7150/ijbs.125547

BibTeX
@article{Wen2026,
  author = {Wen, Weijia and Yuan, Li and Guo, Peng and Zhao, Xueyuan and Chen, Linna and Liu, Songlin and Fan, Haolin and Lin, Lin and Pan, Yu and Chen, Shiyi and Xiao, Yifang and Liu, Pan and Wang, Dongyun and Jiang, Hongye and Wang, Wei and Zhang, Chunyu and Yao, Shuzhong},
  title = {CircCLMP Suppresses Anti-Tumor Immunity by Inhibiting Activation of IRF3 and Interferon Response in Microsatellite Instability-high Endometrial Cancer},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  doi = {10.7150/ijbs.125547}
}
Kostenlos starten →